Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab

References

• TorchilinVPTargeted pharmaceutical nanocarriers for cancer therapy and imagingAAPS J200792E12814717614355
   PubMed Web of Science ®Google Scholar
• YokoyamaMOkanoTIntroduction: targetable drug carriers: present status and a future perspectiveAdv Drug Deliver Rev19962127780
   Web of Science ®Google Scholar
• WahlRLCodyRLHutchinsGDMudgettEEPrimary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucoseRadiology199117937657702027989
   PubMed Web of Science ®Google Scholar
• BremerCNtziachristosVWeitkampBTheilmeierGHeindelWWeisslederROptical imaging of spontaneous breast tumors using protease sensing ‘smart’ optical probesInvest Radiol200540632132715905717
   PubMed Web of Science ®Google Scholar
• MontetXFigueiredoJLAlencarHNtziachristosVMahmoodUWeisslederRTomographic fluorescence imaging of tumor vascular volume in miceRadiology2007242375175817325064
   PubMed Web of Science ®Google Scholar
• ShuklaRThomasTPPetersJLHER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAbBioconjug Chem20061751109111516984117
   PubMed Web of Science ®Google Scholar
• OlayioyeMAIntracellular signaling pathways of ErbB2/HER-2 and family membersBreast Cancer Res20013638538911737890
   PubMed Web of Science ®Google Scholar
• SlamonDJGodolphinWJonesLAStudies of the HER-2/neu proto-oncogene in human breast and ovarian cancerScience198924449057077122470152
   PubMed Web of Science ®Google Scholar
• PegramMDKonecnyGEO’CallaghanCBerytMPietrasRSlamonDJRational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancerJ Natl Cancer Inst2004961073974915150302
   PubMed Web of Science ®Google Scholar
• MontemurroFValabregaGAgliettaMTrastuzumab-based combination therapy for breast cancerExpert Opin Pharmacother2004521819614680438
   PubMed Web of Science ®Google Scholar
• MerlinJLBarberi-HeyobMBachmannNIn vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell linesAnn Oncol200213111743174812419746
   PubMed Web of Science ®Google Scholar
• FerrettiGFeliciAPapaldoPFabiACognettiFHER2/neu role in breast cancer: from a prognostic foe to a predictive friendCurr Opin Obstet Gynecol2007191566217218853
   PubMed Web of Science ®Google Scholar
• XuYHeBWangYJFuQEffect of Herceptin combined with doxorubicin on rat cardiotoxicityAi Zheng2004234367371 Chinese15087020
   PubMedGoogle Scholar
• RaysonDRichelDChiaSJackischCvan der VegtSSuterTAnthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategiesAnn Oncol20081991530153918480068
   PubMed Web of Science ®Google Scholar
• ChenTJChengTHChenCYTargeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRIJ Biol Inorg Chem200914225326018975017
   PubMed Web of Science ®Google Scholar
• SunBRanganathanBFengSSMultifunctional poly(d,l-lactide-co-glycolide)/ montmorillonite (PLGA/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancerBiomaterials200829447548617953985
   PubMed Web of Science ®Google Scholar
• Cirstoiu-HapcaABossy-NobsLBucheggerFGurnyRDelieFDifferential tumor cell targeting of anti-HER2 (Herceptin®) and anti-CD20 (Mabthera®) coupled nanoparticlesInt J Pharm2007331219019617196347
   PubMed Web of Science ®Google Scholar
• AnhornMGWagnerSKreuterJLangerKvon BriesenHSpecific targeting of HER2 overexpressing breast cancer cells with doxorubicinloaded trastuzumab-modified human serum albumin nanoparticlesBioconjug Chem200819122321233118937508
   PubMed Web of Science ®Google Scholar
• SteinhauserISpänkuchBStrebhardtKLangerKTrastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cellsBiomaterials200627284975498316757022
   PubMed Web of Science ®Google Scholar
• SteinhauserIMLangerKStrebhardtKMSpänkuchBEffect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturationBiomaterials200829294022402818653231
   PubMed Web of Science ®Google Scholar
• FeltOBuriPGurnyRChitosan: a unique polysaccharide for drug deliveryDrug Dev Ind Pharm199824119799939876553
   PubMed Web of Science ®Google Scholar
• AgnihotriSAMallikarjunaNNAminabhaviTMRecent advances on chitosan-based micro- and nanoparticles in drug deliveryJ Control Release2004100152815491807
   PubMed Web of Science ®Google Scholar
• AvadiMRSadeghiAMMohammadpourNPreparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation methodNanomedicine201061586319447202
   PubMed Web of Science ®Google Scholar
• AtyabiFMoghaddamFADinarvandRZohuriaan-MehrMJPonchelGThiolated chitosan coated poly hydroxyethyl methacrylate nanoparticles: synthesis and characterizationCarbohydr Polym20087415967
   Web of Science ®Google Scholar
• AtyabiFTalaieFDinarvandRThiolated chitosan nanoparticles as an oral delivery system for amikacin: in vitro and ex vivo evaluationsJ Nanosci Nanotechnol2009984593460319928123
   PubMed Web of Science ®Google Scholar
• EsmaeiliFDinarvandRGhahremaniMHDocetaxel-albumin conjugates: preparation, in vitro evaluation and biodistribution studiesJ Pharm Sci20099882718273018972321
   PubMed Web of Science ®Google Scholar
• MoghaddamFAAtyabiFDinarvandRPreparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticlesNanomedicine20095220821519186220
   PubMed Web of Science ®Google Scholar
• AkhlaghiSPSaremiSOstadSNDinarvandRAtyabiFDiscriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell linesNanomedicine20106568969720172052
   PubMed Web of Science ®Google Scholar
• SaremiSAtyabiFAkhlaghiSPOstadSNDinarvandRThiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluationInt J Nanomedicine2011611912821289989
   PubMed Web of Science ®Google Scholar
• TanMLChoongPFDassCRReview: doxorubicin delivery systems based on chitosan for cancer therapyJ Pharm Pharmacol200961213114219178759
   PubMed Web of Science ®Google Scholar
• PenistonPJohnsonELProcess for depolymerization of chitosan11251975United States Patent 3922260
   Google Scholar
• ChuangW-YYoungT-HYaoC-HChiuWYProperties of the poly(vinyl alcohol)/chitosan blend and its effect on the culture of fibroblast in vitroBiomaterials199920161479148710458561
   PubMed Web of Science ®Google Scholar
• El-GibalyIDevelopment and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheresInt J Pharm20022491–272112433430
   PubMed Web of Science ®Google Scholar
• SonYJJangJ-SChoYWBiodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effectJ Control Release2003911–213514512932645
   PubMed Web of Science ®Google Scholar
• Hyung ParkJKwonSLeeMSelf-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activityBiomaterials200627111912616023198
   PubMed Web of Science ®Google Scholar
• HjelmHHjelmKSjöquistJProtein A from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulinsFEBS Lett197228173764630462
   PubMed Web of Science ®Google Scholar
• GhoseSHubbardBCramerSMBinding capacity differences for antibodies and Fc-fusion proteins on protein A chromatographic materialsBiotechnol Bioeng200796476877916817242
   PubMed Web of Science ®Google Scholar
• ColesDJYangSMinchinRFTothIThe characterization of a novel dendritic system for gene delivery by isothermal titration calorimetryBiopolymers200890565165418481807
   PubMed Web of Science ®Google Scholar
• KocbekPObermajerNCegnarMKosJKristlJTargeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibodyJ Control Release20071201–2182617509712
   PubMed Web of Science ®Google Scholar
• ZhuSHongMTangGPartly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation styleBiomaterials20103161360137119883938
   PubMed Web of Science ®Google Scholar
• ZhuSHongMZhangLTangGJiangYPeiYPEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulationPharm Res201027116116419862607
   PubMed Web of Science ®Google Scholar
• KakinokiAKaneoYIkedaYTanakaTFujitaKSynthesis of poly(vinyl alcohol)-doxorubicin conjugates containing cis-aconityl acid-cleavable bond and its isomer dependent doxorubicin releaseBiol Pharm Bull200831110311018175951
   PubMed Web of Science ®Google Scholar
• YooHSLeeEAParkTGDoxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkagesJ Control Release2002821172712106973
   PubMed Web of Science ®Google Scholar
• LuDLiangJFanYGuZZhangXIn vivo evaluation of a pH-sensitive pullulan–doxorubicin conjugateAdv Eng Mater2010129B496503
   Web of Science ®Google Scholar